Corrigendum to <‘Efficacy and safety of anti-interleukin-5 therapy in patients with chronic obstructive pulmonary disease: A meta-analysis of randomized, controlled trials’>[J Microbiol Immunol Infect 55 (1) (2022) 26–35, (S168411822030253X), (10.1016/j.jmii.2020.11.001)]
Shao Huan Lan, Chih Cheng Lai, Shen Peng Chang, Chun Chun Hsu, Cheng Hsin Chen, Ya Hui Wang, Yueh Lan Huang, Cheng Yi Wang, You Shuei Lin
研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審